Deutsche Bank’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Deutsche Bank’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-28,110	Closed	-$83K	–	4398
2022 Q1	$83K	Sell	28,110 -3,158	-10%	-$11.9K	﹤0.01%	3647
2021 Q4	$141K	Buy	31,268 +1,506	+5%	+$7.14K	﹤0.01%	3549
2021 Q3	$145K	Sell	29,762 -194,825	-87%	-$1.07M	﹤0.01%	3726
2021 Q2	$1.53M	Sell	224,587 -16,010	-7%	-$129K	﹤0.01%	2467
2021 Q1	$1.7M	Buy	240,597 +60,633	+34%	+$437K	﹤0.01%	2297
2020 Q4	$1.13M	Sell	179,964 -59,047	-25%	-$347K	﹤0.01%	2363
2020 Q3	$1.29M	Buy	239,011 +138,678	+138%	+$687K	﹤0.01%	2019
2020 Q2	$524K	Buy	100,333 +88,985	+784%	+$395K	﹤0.01%	2609
2020 Q1	$36K	Sell	11,348 -670	-6%	-$2.47K	﹤0.01%	3699
2019 Q4	$47K	Buy	12,018 +2,960	+33%	+$10.3K	﹤0.01%	4003
2019 Q3	$38K	Sell	9,058 -87,195	-91%	-$349K	﹤0.01%	4070
2019 Q2	$381K	Sell	96,253 -217,883	-69%	-$1.04M	﹤0.01%	3458
2019 Q1	$1.68M	Sell	314,136 -2,525	-0.8%	-$16.3K	﹤0.01%	2630
2018 Q4	$1.62M	Buy	316,661 +32,936	+12%	+$250K	﹤0.01%	2540
2018 Q3	$2.75M	Sell	283,725 -295,608	-51%	-$2.98M	﹤0.01%	2640
2018 Q2	$5.91M	Buy	579,333 +80,282	+16%	+$908K	﹤0.01%	2171
2018 Q1	$6.49M	Buy	499,051 +122,766	+33%	+$1.83M	﹤0.01%	2007
2017 Q4	$6.73M	Sell	376,285 -19,989	-5%	-$417K	﹤0.01%	1784
2017 Q3	$9.94M	Sell	396,274 -25,999	-6%	-$605K	0.01%	1457
2017 Q2	$10.2M	Buy	422,273 +181,987	+76%	+$4.02M	0.01%	1390
2017 Q1	$4.62M	Buy	240,286 +113,164	+89%	+$1.78M	﹤0.01%	1730
2016 Q4	$1.96M	Sell	127,122 -5,449	-4%	-$70.7K	﹤0.01%	2277
2016 Q3	$1.72M	Buy	132,571 +37,391	+39%	+$496K	﹤0.01%	2456
2016 Q2	$1.32M	Buy	95,180 +66,840	+236%	+$984K	﹤0.01%	2688
2016 Q1	$429K	Sell	28,340 -408	-1%	-$6.24K	﹤0.01%	3304
2015 Q4	$543K	Sell	28,748 -21,423	-43%	-$409K	﹤0.01%	3232
2015 Q3	$951K	Sell	50,171 -15,243	-23%	-$380K	﹤0.01%	2987
2015 Q2	$1.68M	Buy	65,414 +24,930	+62%	+$707K	﹤0.01%	2598
2015 Q1	$1.26M	Buy	40,484 +2,284	+6%	+$65.6K	﹤0.01%	2744
2014 Q4	$1.47M	Buy	38,200 +31,387	+461%	+$749K	﹤0.01%	2912
2014 Q3	$165K	Buy	+6,813	New	+$178K	﹤0.01%	4200
2014 Q2	–	Sell	-8	Closed	–	–	6121
2014 Q1	$0	Buy	+8	New	+$316	﹤0.01%	5838
2013 Q4	–	Sell	-4,222	Closed	-$161K	–	5770
2013 Q3	$161K	Sell	4,222 -42	-1%	-$1.5K	﹤0.01%	4218
2013 Q2	$153K	Buy	+4,264	New	+$183K	﹤0.01%	3987

Other funds holding PRTK

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FIG

Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

Deutsche Bank's PRTK Position: Q2 2022 in Review

Deutsche Bank sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2022, closing a stake of 28,110 shares — an estimated $83K sold.

Deutsche Bank first reported a position in PRTK in Q2 2013 and held it in 34 quarters. The position peaked at $10.2M in Q2 2017. 84 funds tracked by Wall St. Rank hold PRTK as of Q2 2022.

Deutsche Bank reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
Deutsche Bank sold 28,110 Paratek Pharmaceuticals, Inc. shares in Q2 2022, an estimated $83K.
Deutsche Bank first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and held it in 34 quarters.
Deutsche Bank's Paratek Pharmaceuticals, Inc. position peaked at $10.2M in Q2 2017.
84 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.